Eli Lilly Stock Rises on Expanded Gate Bioscience Deal

Eli Lilly shares traded around $1,161.50, up approximately 1.6%, Tuesday morning after securing exclusive worldwide rights to products from its expanded Gate Bioscience partnership. The deal grants access to potential medicines aimed at...